探索对PrEP选择和mHealth干预的看法和偏好:来自ImPrEP CAB-巴西研究的见解
Cristina Pimenta1, Claudio G Mann1, Brenda Hoagland1
1Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
巴西的年轻性和性别少数群体 (SGM) 偏爱长效可注射卡博特格拉维尔 (CAB-LA) 作为艾滋病毒暴露前预防 (PrEP) 由于方便. 一个mHealth工具有效地支持了PrEP决策.
科学领域:
- 实施科学 实施科学
- 公共卫生 公共卫生
- 预防艾滋病毒 预防艾滋病毒
背景情况:
- 长效注射性卡博特格拉维尔 (CAB-LA) 用于暴露前预防 (PrEP) 已被证明是有效的,但实施策略需要进一步研究.
- 在ImPrEP CAB巴西研究中进行定性研究,以评估PrEP选择的看法和mHealth干预的可接受性.
研究的目的:
- 评估年轻的性和性别少数群体 (SGM) 中的PrEP选择偏好.
- 评估mHealth工具对PrEP教育和决策的可接受性和实用性.
主要方法:
- 定性研究涉及120名参与ImPrEP CAB巴西实施研究的半结构面试.
- 参与者接受了标准护理 (SOC) 或SOC以及一个mHealth工具,其中包含有关HIV预防选项的视频.
- 传统的内容分析被用来编码采访数据.
主要成果:
- 大多数参与者选择CAB-LA而不是口服PrEP,理由是方便,实用性和感知到更高的疗效.
- 对CAB-LA的障碍包括注射和疼痛的恐惧;对口服PrEP的障碍包括坚持挑战和副作用.
- 对于PrEP教育和决策,mHealth工具被认为是有用和充分的.
结论:
- 提供全面的信息和支持对于SGM之间的知情PrEP决策至关重要.
- 移动健康工具显示出高度的可取性和实用性,显示了将其整合到艾滋病毒预防服务中的潜力.
更多相关视频
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
相关概念视频
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Cancer Prevention
Some...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Sexually Transmitted Infections
